Standard Dosing Schedule for Prolia
Prolia (denosumab) is injected subcutaneously once every 6 months to treat osteoporosis in postmenopausal women, men at high risk for fracture, or patients with glucocorticoid-induced osteoporosis.[1]
Who Gets Prolia and Why the 6-Month Interval?
Adults over 18 with specific bone loss conditions receive it this way. The interval stems from its pharmacokinetics: denosumab binds RANKL to inhibit osteoclasts, providing sustained bone density protection for up to 6 months per dose.[1][2]
What If I Miss a Dose?
Administer the next dose as soon as possible, then resume every 6 months from that point. Do not double up. Calcium and vitamin D supplements are required daily alongside treatment.[1]
How Is the Injection Given?
A healthcare provider gives the 60 mg dose in the thigh, abdomen, or upper arm. Self-injection is not approved.[1]
Duration of Treatment
Continue indefinitely unless bone density stabilizes or side effects occur. Stopping abruptly risks rapid bone loss (rebound fractures); transition to bisphosphonates like alendronate if discontinuing.[2]
Common Side Effects and Injection Concerns
Patients report back/joint/muscle pain, high cholesterol, or bladder infections. Rare jaw osteonecrosis or atypical femur fractures prompt monitoring. No data links frequency to increased risks beyond standard use.[1][2]
[1]: Prolia Prescribing Information (Amgen)
[2]: FDA Label for Prolia